Company: CDLX
Filing Date: 2025-03-12
Form Type: 10-K
Source: 0001666071-25-000034
Chunk: 8

Company: Cardlytics, Inc.
Filing Date: 2025-03-12
Form: 10-K
Item: Item 15
Chunk 8
---
ITEM 15. EXHIBIT AND FINANCIAL STATEMENT SCHEDULES

(a)The following documents are filed as part of this Annual Report:

(i)Consolidated Financial Statements and Reports of Independent Registered Public Accounting Firm are shown in the Index to Financial Statements included in Part II, Item 8 of this Annual Report on Form 10-K.

(ii)All financial statement schedules are omitted because they are not applicable or the required information is shown in the financial statements or notes thereto.

(iii)Exhibits are incorporated herein by reference or are filed with this Annual Report as indicated below.

(b)Exhibits:

  Incorporated by ReferenceExhibitExhibit DescriptionSchedule/FormFileNumberExhibitFiling Date3.1  Amended and Restated Certificate of Incorporation of the Registrant  S-1  333-222531  3.2  1/12/20183.2  Amended and Restated Bylaws of the Registrant  S-1  333-222531  3.4  1/12/20184.1Form of Common Stock Certificate of the RegistrantS-1/A333-2225314.11/29/20184.2Description of Cardlytics, Inc. Common Stock10-K001-383864.33/3/20204.3Indenture, dated as of September 22, 2020, by and between the Registrant ant U.S. Bank National Association, as Trustee.8-K    001-383864.19/22/20204.4Form of Global Note, representing the Registrant’s 1.00% Convertible Senior Notes due 2025 (included as Exhibit A to the Indenture filed as Exhibit 4.4)8-K001-383864.29/22/20204.5Indenture, dated as of April 1, 2024, by and between the Registrant ant U.S. Bank National Association, as Trustee.8-K001-383864.14/1/20244.6Form of Global Note, representing the Registrant’s 4.25% Convertible Senior Notes due 2029 (included as Exhibit A to the Indenture filed as Exhibit 4.6)8-K001-383864.24/1/202410.1Office Lease Agreement, dated as of August 5, 201